You are here: Industry Insights > Oxford Immunotec

News List

Oxford Immunotec partners with UK COVID-19 human challenge study pharmatimes
May 19, 2021
UK diagnostic company Oxford Immunotec has collaborated with the UK COVID-19 human challenge study to analyse the T cell responses to SARS-CoV-2 infection in participants using its T-SPOT Discovery testing kit.
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection prnasia
March 05, 2021
Oxford Immunotec Global PLC., a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative detection of a cell mediated (T cell) immune response to ...
Valneva partners with Oxford Immunotec on T cell analysis for COVID-19 vaccine pharmatimes
January 15, 2021
Valneva has chosen UK-based diagnostics company Oxford Immunotec to perform T cell testing on participants receiving its COVID-19 vaccine candidate (VLA2001) in a Phase I/II study.
UK to collaborate with Oxford Immunotec to evaluate COVID-19 vaccine T cell responses expresspharma
October 23, 2020
T cell immunity is thought to be essential to protect against infection from the SARS-COV-2 coronavirus and could provide longer-term immunity than antibodies.
Oxford Immunotec releases the T-SPOT Discovery SARS-CoV-2 kit for COVID-19 research expresspharma
May 21, 2020
This research kit could make a significant contribution towards development of a new tool to manage the COVID-19 pandemic, which in turn could help to bring nations out of their current lockdowns in a faster, safer and more controlled manner.